The Uromigos

Health EN ↓ Odcinki: 485

Broadcasting the latest developments in GU cancerHosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer CenterTom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.uromigos.org

Autor

The Uromigos

Kategoria

Health

Strona podcastu

www.uromigos.org

Ostatni odcinek

5 paź 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Episode 10: COVID-19 and Renal Cancer: A Patient's Perspective 16.03.2020 27:09

Dena Battle (President, KCCure) asks key patient-focused questions about kidney cancer management during the COVID-19 pandemic. 

Episode 9: COVID-19 and Cancer: An International Perspective 16.03.2020 21:58

Five members of the groups from Europe and North America discuss the current situation for cancer patients. 

Episode 8: COVID-19 and Cancer Patients 13.03.2020 21:54

Professor Tom Powles and Dr. Brian Rini discuss the virus with an expert, Ronan Breen. 

Episode 7: The First Uromigos Prostate Cancer Podcast 27.02.2020 25:32

Silke Gillessen and Chris Sweeney discuss how data from recent ESMO and GU ASCO meetings has changed the way they treat prostate cancer. 

Episode 6: Urothelial Cancer Highlights from ASCO GU 2020 26.02.2020 20:08

In this episode, Professor Tom Powles and Dr. Brian Rini talk to Dr. Kala Sridhar about key developments in urothelial cancer presented at ASCO GU 2020. 

Episode 5: Renal Highlights from ASCO GU 2020 24.02.2020 10:14

Professor Tom Powles and Dr. Brian Rini broadcast from ASCO GU 2020, San Francisco. 

Episode 4: Treatment Choices in Front Line Advanced Renal Cancer 11.02.2020 26:39

Dr. Brian Rini and Professor Tom Powles ask David McDermott about how he chooses between ipilimumab/nivolumab or axitinib/pebrolizumab intreatment options

Episode 1: Introduction to Uromigos Podcasts 11.02.2020 3:20

Professor Tom Powles and Dr. Brian Rini discuss the purpose of the podcasts and how to complain if you don’t like them

Episode 2: The Current role of IO in Front-line Advanced Urothelial Cancer 11.02.2020 30:18

Matthew Galski and Petros Grivas engage in a discussion with Professor Tom Powles and Dr. Brian Rini about IMVIGOR130.

Episode 3: Pembrolizumab in Non-Muscle Invasive Bladder Cancer 11.02.2020 33:02

Guests Dr. Arjun Balar and Professor Seth Lerner give an overview of the recent FDA approval of pembrolizumab in this indication to Professor Tom Powles and Dr. Brian Rini.